Fulgent Genetics, Inc.
FLGT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $84 | $82 | $73 | $76 |
| % Growth | 2.8% | 11.4% | -3.6% | – |
| Cost of Goods Sold | $49 | $47 | $45 | $44 |
| Gross Profit | $36 | $34 | $28 | $32 |
| % Margin | 42.2% | 42.1% | 38.6% | 41.8% |
| R&D Expenses | $14 | $13 | $12 | $12 |
| G&A Expenses | $23 | $26 | $25 | $24 |
| SG&A Expenses | $35 | $39 | $34 | $34 |
| Sales & Mktg Exp. | $12 | $12 | $8 | $10 |
| Other Operating Expenses | $2 | $2 | $2 | $2 |
| Operating Expenses | $51 | $54 | $48 | $48 |
| Operating Income | -$15 | -$20 | -$20 | -$16 |
| % Margin | -18.3% | -24.1% | -26.9% | -21.2% |
| Other Income/Exp. Net | $9 | -$2 | $8 | $8 |
| Pre-Tax Income | -$6 | -$22 | -$12 | -$8 |
| Tax Expense | $1 | -$2 | $0 | -$2 |
| Net Income | -$7 | -$19 | -$12 | -$6 |
| % Margin | -7.9% | -23.2% | -15.7% | -7.7% |
| EPS | -0.21 | -0.61 | -0.37 | -0.19 |
| % Growth | 65.6% | -64.9% | -94.7% | – |
| EPS Diluted | -0.21 | -0.61 | -0.37 | -0.19 |
| Weighted Avg Shares Out | 31 | 31 | 31 | 31 |
| Weighted Avg Shares Out Dil | 31 | 31 | 31 | 31 |
| Supplemental Information | – | – | – | – |
| Interest Income | $8 | $8 | $8 | $8 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $6 | $6 | $6 | $6 |
| EBITDA | -$0 | -$15 | -$6 | -$10 |
| % Margin | -0.1% | -18.9% | -7.9% | -13% |